-
公开(公告)号:US20250049731A1
公开(公告)日:2025-02-13
申请号:US18912238
申请日:2024-10-10
Applicant: University of Washington
Inventor: Robert Divine , Ivan Vulovic , David Baker , William H. Sheffler , Franziska Seeger
Abstract: Polypeptides are disclosed comprising an (Fc) binding domain, a helical polypeptide monomer, and an oligomer domain, polymers thereof, and uses thereof.
-
公开(公告)号:US20250011437A1
公开(公告)日:2025-01-09
申请号:US18627108
申请日:2024-04-04
Applicant: The Board of Trustees of the Leland Stanford Junior University , University of Washington
Inventor: Kenan Christopher Garcia , David Baker , Claudia Yvonne Janda , Luke Dang , James Daniel Moody
Abstract: Wnt signaling agonist compositions and methods for their use are provided. Wnt signaling agonists of the invention comprise a frizzled binding moiety, which is fused or conjugated to an LRP5 or LRP6 binding moiety.
-
公开(公告)号:US20230357323A1
公开(公告)日:2023-11-09
申请号:US18003572
申请日:2021-06-25
Applicant: University of Washington
Inventor: Stephanie Berger , Franziska Seeger , David Baker , Ta-Yi Yu
CPC classification number: C07K14/001 , C12N15/63 , A61P29/00
Abstract: The present disclosure provides human 1L-23R (WL-23R) binding polypeptides, conditionally maximally active SilL˜23R binding proteins, multimers thereof, and methods for using the polypeptides and binding proteins for therapeutic use.
-
公开(公告)号:US20230279055A1
公开(公告)日:2023-09-07
申请号:US18177367
申请日:2023-03-02
Inventor: David Baker , Tamuka Chidyausiku , Jason C. Klima , Enrique Marcos Benteo , F. Xavier Gomis Rüth , Soraia Dos Reis Mendes , Ulrich Eckhard , Marta Nadal Rovira , Jorge Luis Roel Touris
Abstract: The disclosure provides antibody-like polypeptides of the formula X1-X2-X3-X4-X5-X6-X7-X8-X9-X10-X11-X12-X13-X14-X15, wherein the domains are as defined herein, nucleic acids encoding the polypeptides, and methods for use and design of the polypeptides.
-
公开(公告)号:US20230159595A1
公开(公告)日:2023-05-25
申请号:US17934343
申请日:2022-09-22
Applicant: University of Washington
Inventor: David Baker , Jacob B. BALE , Neil P. KING , William H. SHEFFLER , Daniel ELLIS
IPC: C07K14/00
CPC classification number: C07K14/00
Abstract: Synthetic nanostructures, polypeptides that are useful, for example, in making synthetic nanostructures, and methods for using such synthetic nanostructures are disclosed herein.
-
公开(公告)号:US20220354893A1
公开(公告)日:2022-11-10
申请号:US17815092
申请日:2022-07-26
Inventor: Kenan Christopher Garcia , Jonathan Sockolosky , David Baker , Chris King
Abstract: Engineered orthogonal cytokine receptor/ligand pairs, and methods of use thereof, are provided.
-
公开(公告)号:US20220235110A1
公开(公告)日:2022-07-28
申请号:US17698553
申请日:2022-03-18
Applicant: UNIVERSITY OF WASHINGTON , THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Inventor: Daniel Adriano Silva Manzano , Shawn Yu , Umut Ulge , David Baker , Kenan Christopher Garcia , Jamie Spangler , Carl WALKEY
Abstract: De novo designed polypeptides that bind to IL-2 receptor βc heterodimer (IL-2Rβc), IL-4 receptor αc heterodimer (IL-4Rαc), or IL-13 receptor α subunit (IL-13Rα) are disclosed, as are methods for using and designing the polypeptides.
-
公开(公告)号:US11117944B2
公开(公告)日:2021-09-14
申请号:US16905669
申请日:2020-06-18
Applicant: UNIVERSITY OF WASHINGTON , THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Inventor: Daniel Adriano Silva Manzano , Shawn Yu , Umut Ulge , David Baker , Kenan Christopher Garcia , Jamie Spangler , Carl Walkey , Alfredo Quijano Rubio , Brian Weitzner
Abstract: De novo designed polypeptides that bind to IL-2 receptor βγc heterodimer (IL-2Rβγc), IL-4 receptor αγc heterodimer (IL-4Rαγc), or IL-13 receptor α subunit (IL-13Rα) are disclosed, as are methods for using and designing the polypeptides.
-
公开(公告)号:US11028383B2
公开(公告)日:2021-06-08
申请号:US16676253
申请日:2019-11-06
Applicant: UNIVERSITY OF WASHINGTON , UNIVERSITY OF UTAH
Inventor: Neil King , Wesley Sundquist , Joerg Votteler , Yang Hsia , David Baker , Jacob Bale , Marc Lajoie , Gabriel Butterfield , Elizabeth Gray , Daniel Stetson
IPC: C12N9/88 , C07K14/00 , C07K14/435
Abstract: The application discloses multimeric assemblies including multiple oligomeric substructures, where each oligomeric substructure includes multiple proteins that self-interact around at least one axis of rotational symmetry, where each protein includes one or more polypeptide-polypeptide interface (“O interface”); and one or more polypeptide domain that is capable of effecting membrane scission and release of an enveloped multimeric assembly from a cell by recruiting the ESCRT machinery to the site of budding by binding to one or more proteins in the eukaryotic ESCRT complex (“L domain”); and where the multimeric assembly includes one or more subunits comprising one or more polypeptide domain that is capable of interacting with a lipid bilayer (“M domain”), as well as membrane-enveloped versions of the multimeric assemblies.
-
公开(公告)号:US10766929B2
公开(公告)日:2020-09-08
申请号:US16483865
申请日:2018-03-15
Applicant: UNIVERSITY OF WASHINGTON
Inventor: David Baker , Aaron Arthur Chevalier , Gabriel Jacob Rocklin , Christopher David Bahl , Lance Joseph Stewart , Daniel Adriano Silva Manzano , Deborah L. Fuller , Merika Treants Koday , Jason Gilmore
IPC: A61K38/00 , C07K14/00 , A61P31/16 , C07K16/00 , G01N33/569
Abstract: Polypeptides that bind to viral hemagglotinin are disclosed and methods for their use in treating or limiting influenza infection, and diagnosing influenza infection.
-
-
-
-
-
-
-
-
-